Search results
Results From The WOW.Com Content Network
Before being spun off, Baxalta acquired SuppreMol (a German company) for US$225 million. [4] Baxalta also acquired the blockbuster leukemia drug Oncaspar from Sigma-Tau Finanziaria S.p.A. for US$900 million. [1] [5] In August 2015, Shire Plc made an unsolicited $30.6 billion stock offer for the company [6] [7] increasing the Baxalta share price ...
Shire plc. Shire plc was a UK -founded Jersey -registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. [ 2] The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
August 1962 (age 61–62) Nationality. Belgian. Alma mater. University of Louvain. Title. CEO, Alexion Pharmaceuticals. Ludwig Norbert Michel Hantson (born August 1962) [1] is a Belgium businessman, the CEO of Alexion Pharmaceuticals since March 2017. He was the president and CEO of Baxalta, an American biopharmaceutical company, from 2015 to 2016.
After years of investing in self-checkouts, Five Below, Dollar General and others are refocusing on human cashiers, citing long-running concerns about lost inventory.
Takeda Midosuji Building, headquarters of Takeda Pharmaceutical Company, in Chuo-ku, Osaka, Japan. Takeda Pharmaceuticals was founded in 1781, and was incorporated on January 29, 1925. [ 12] One of the firm's mainstay drugs is Actos ( pioglitazone ), a compound in the thiazolidinedione class of drugs used in the treatment of type 2 diabetes.
Why Doximity Stock Was Soaring Today. Jeremy Bowman, The Motley Fool. August 9, 2024 at 1:50 PM. Shares of Doximity (NYSE: DOCS), the social network for doctors, were jumping today after the ...